Ptc Therapeutics (PTCT) Goodwill & Intangibles (2017 - 2026)

Ptc Therapeutics' Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $463.0 million for Q1 2026.

• On a quarterly basis, Goodwill & Intangibles rose 130.65% year-over-year to $463.0 million in Q1 2026; TTM through Mar 2026 was $463.0 million, a 130.65% increase from a year earlier, with the FY2025 full-year figure at $471.1 million, up 472.13% from the prior year.
• Goodwill & Intangibles declined to $463.0 million in Q1 2026 per PTCT's latest filing, from $471.1 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $846.0 million in Q1 2022 and bottomed at $82.3 million in Q4 2024.
• The 5-year median for Goodwill & Intangibles is $471.1 million (2025), against an average of $514.0 million.
• Across the five-year window, Goodwill & Intangibles tumbled 82.17% in 2024 and soared 472.13% in 2025, its largest moves.
• Year by year, Goodwill & Intangibles stood at $788.2 million in 2022, then sank by 41.41% to $461.8 million in 2023, then tumbled by 82.17% to $82.3 million in 2024, then surged by 472.13% to $471.1 million in 2025, then retreated by 1.71% to $463.0 million in 2026.
• Per Business Quant, the three latest PTCT Goodwill & Intangibles figures stand at $463.0 million (Q1 2026), $471.1 million (Q4 2025), and $478.8 million (Q3 2025).